MedPath

SE OF BENZODIAZEPINE IN THE TREATMENT OF ALCOHOL WITHDRAWAL SYMPTOMS IN A TEACHING HOSPITAL.

Not Applicable
Conditions
Health Condition 1: F102- Alcohol dependence
Registration Number
CTRI/2019/04/018624
Lead Sponsor
itte Deemed to be University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

inclusion: In patients in psychiatry de-addiction ward.

Patients who are willing to participate in the study.

Age group 18 and above.

Exclusion Criteria

exclusion: Patients diagnosed with psychosis.

Severe medical illness or injuries.

Other substance abuse(except nicotine)

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The study assesses the efficacy of different Benzodiazepines in reducing alcohol withdrawal syndrome. <br/ ><br>Optimizing the therapeutic outcomes and preventing further complications.Timepoint: Single point <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
seful in identifying rationality of drugs. <br/ ><br>Timepoint: Single point
© Copyright 2025. All Rights Reserved by MedPath